ArticleFrontiers in medicine2025
Alterations in the composition of meibomian gland secretions in patients with meibomian gland dysfunction based on Raman spectroscopy.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence of asymptomatic meibomian gland dysfunction in the general adult population: a systematic review and meta-analysis.Frontiers in medicine · 2026Pooled it
- Dry Eye Disease: From Mechanisms to Management and Future Directions.Journal of clinical medicine · 2026Review
- Development of Autologous Serum Ocular Insert for Chronic Dry Eye Disease.Pharmaceutics · 2026Article
- Composition of Human Meibomian Gland Secretions: Insights from TOF-SIMS Analysis.International journal of molecular sciences · 2026Article
- Impact of lotilaner ophthalmic solution 0.25% on disease severity in patients withFrontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate biochemical alterations in meibum from patients with obstructive meibomian gland dysfunction (MGD) using Raman spectroscopy, with a focus on lipid saturation, molecular conformation, and lipid-protein composition. Methods: Meibum samples from healthy individuals and MGD patients with obstructive MGD were collected by eyelid expression, smeared onto gold-coated silicon slides, stored at low temperature, and analyzed within 2 h. Raman band-intensity ratios were used to quantify lipid unsaturation (I1659/I1438, I3013/I2860), lipid molecular conformation (I2888/I2860), and lipid-to-protein balance (I1659/I1161, I3013/I1161). Raman mapping was used to assess spatial distribution of biochemical components. Results: Meibum was lipid-rich in both groups. Ratios associated with lipid unsaturation (I1659/I1438 and I3013/I2860) were significantly lower in MGD samples than in healthy controls, indicating reduced unsaturated lipids. Ratios reflecting lipid-to-protein balance (I1659/I1161 and I3013/I1161) were significantly higher in MGD, suggesting a relative reduction in protein content. The symmetric-to-asymmetric lipid ratio (I2888/I2860) also differed significantly between groups, though with a small absolute effect size. Raman mapping further revealed a heterogeneous spatial distribution of lipids and proteins in MGD meibum. Conclusion: Compared with healthy meibum, MGD meibum exhibits reduced unsaturated lipid content, altered lipid-protein balance, and increased biochemical heterogeneity, accompanied by subtle conformational lipid changes. These findings indicate that both lipid composition and microstructural organization are disrupted in MGD. This study supports the potential of Raman spectroscopy serve as a valuable tool for analyzing meibum composition and detecting pathological changes in MGD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.